Navigation Links
STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China
Date:2/29/2008

meeting in Japan during January, STAAR's Visian ICL and TICL were used in approximately 60% of those procedures. "Our goal in China over time is to at least replicate the market penetration we are achieving in South Korea," Mr. Caldwell added.

Made of STAAR's proprietary, highly biocompatible Collamer(R) material, the ICL, TICL and the ICH are the only minimally invasive foldable lenses of their kind approved for the Chinese commercial market. As a result of the unique foldable design, the ICL procedure allows an incision up to 50% smaller than competing technology, and its placement in the eye behind the iris provides a more aesthetically pleasing outcome. These approvals in China are for treatments of myopic patients with refractive errors between -3.00 and -20.0 and astigmatism up to six diopters. The hyperopic approval is for patients with refractive errors between +1.0 to +4.0.

About STAAR Surgical

STAAR is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. More information is available at http://www.staar.com.

Safe Harbor

All statements in this press release that are not statements of historical fact are forward-looking statements, including any statements of the plans, strategies, and objectives of management for future operations, any statements regarding expectations for success of the ICL, TICL or other products in China, the U.S. or other markets, statements of belief and any statements of assumptions un
'/>"/>

SOURCE STAAR Surgical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
2. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
3. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
4. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
5. Surgical and Trauma Wound Care Market to Tie Up $7 Billion in Sales by 2011
6. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
7. Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic
8. Sunnylife Global Announces Completion of Surgical Wing of Xiang Tan World Friendship Hospital
9. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
10. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
11. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... Personalized Medicine, presented two studies at the International Spine Intervention Society’ ... 28th, 2015 through to August 1st, 2015. With a focus on evidence-based research ...
(Date:8/28/2015)... Brooklyn, NY (PRWEB) , ... August 28, 2015 , ... Since the initial launch of ... with their quirky humor and excellent customer service. Images such as the Fonz in ... website to add some flavor to the humdrum spectroscopy field. , FireflySci is ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
(Date:8/27/2015)... -- HUYA Bioscience International (HUYA) today announced the sponsorship of ... HTLV-1, held this week at the University of Tokyo ... is to promote research on HTLV-1 and HTLV-1-associated diseases, ... research related to these fields to advance science, the ... to support this prestigious conference," said Mireille Gillings ...
Breaking Biology Technology:Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4
... ) announced today that it will hold a conference call ... first quarter 2008,earnings. On Thursday, May 8, 2008 at 4:00 ... headquarters at 1450 Infinite Drive,in Louisville, CO., ... Kenneth J. Collins, President and CEO, and other members ...
... 29 Cord Blood America,Inc. (OTC Bulletin Board: ... ( http://www.cordblood-america.com ) focused on,bringing the life ... and,internationally, today reported that Matthew Schissler, CEO, in ... resulted in an 820,percent increase in assets and ...
... microscopic device that can construct nano machines have been ... International Journal of Nanomanufacturing from Inderscience Publishers, researchers describe ... 1986 book, The Engines of Creation, K Eric Drexler ... create an assembler, a microscopic device, a robot, that ...
Cached Biology Technology:Replidyne to Report First Quarter 2008 Earnings 2Replidyne to Report First Quarter 2008 Earnings 3Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined 2Are nanobots on their way? 2Are nanobots on their way? 3
(Date:8/6/2015)... 6, 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced collaboration with Microsoft on biometric ... Microsoft leveraged Synaptics, deep expertise in human interface ... Through stringent testing, Synaptics, advanced image ... Microsoft,s Precision TouchPad (PTP) specification empowering OEMs with ...
(Date:8/4/2015)... , Aug. 04, 2015 ... http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition of ... (Hardware, Software, and Service), Sub-Segment (Computer Forensics, ... Forensics), Tool Types, Service, Vertical and Region ... to their offering. By Component ...
(Date:7/31/2015)... julio de 2015 BGI llevará a cabo la ... 22 al 25 de octubre de 2015, en ... celebra su décimo aniversario este año. Desde su inauguración ... las reuniones anuales más influyentes del mundo en los ... conferencias científicas más dinámicas, entusiastas y amenas. ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... Stories of environmental damage and their consequences always ... country, usually a tropical one with lush rainforests and ... familiar animals are unfolding all the time in our ... from animal hosts to people when ecosystems are disrupted. ...
... State University have developed a rapid, multiplexed genotyping method ... warfarin dose. The related report by Yang et ... by SELDI-TOF Mass Spectrometry," appears in the March 2010 ... Warfarin is an anti-coagulant that is commonly used ...
... People may avoid milk and other dairy products due ... foods may not only be unnecessary to manage the ... a panel of experts assembled by the National Institutes ... Conference on Lactose Intolerance and Health was convened to ...
Cached Biology News:Emerging tick-borne disease 2Emerging tick-borne disease 3Emerging tick-borne disease 4Emerging tick-borne disease 5Emerging tick-borne disease 6Avoiding dairy due to lactose intolerance is unnecessary in most cases 2Avoiding dairy due to lactose intolerance is unnecessary in most cases 3Avoiding dairy due to lactose intolerance is unnecessary in most cases 4
... Transcriptase (M-MLV RT) is an RNA-dependent DNA polymerase ... long messenger RNA templates (>5kb). The enzyme is ... and consists of a single subunit with a ... of M-MLV RT is weaker than the commonly ...
... Collection of Cell Cultures (ECACC) in conjunction ... the West of England, Bristol, UK, have ... control of HER2, oestrogen and progresterone receptor ... sections of formalin fixed, breast cancer cell ...
... introduced the highly potent TURBO DNase (patent pending) ... was set in DNA removal capabilities. TURBO DNase ... that is much more efficient than wild type ... unwanted DNA. TURBO DNase binds DNA substrates 6-fold ...
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
Biology Products: